UNSPSC 51283704: Cefetrizole

This classification denotes a cephalosporin antibiotic with the molecular formula C16H15N5O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 61K37E446T, chemically known as (6r,7r)-8-oxo-7-(2-(2-thienyl)acetamido)-3-((s-triazol-3-ylthio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylic acid. but generally known as cefetrizole, which bears US NIH Compound Identifier 193956. European Medicines Agency schedules Cefetrizole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07393MIG.

UNSPSC 51283704 Cefetrizole, a Commodity code, nominally describes a specific antibiotic pharmaceutical, but recent state and local procurement activity tagged to this code shows minimal alignment with the code's stated product scope. The opportunities posted under this code span pharmaceuticals procurement more broadly—including naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals through cooperative purchasing. State and local issuing bodies using this code include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local governments across multiple jurisdictions including Oregon). The mismatch between the code's specific pharmaceutical designation and the broader pharmaceutical and medical supply categories actually being procured suggests either tagging inconsistency in source systems or code application drift in state and local procurement offices.

Recent activity shows geographic spread across Florida, Texas, Minnesota, and Oregon, with issuing bodies ranging from single counties to multistate cooperative agreements. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2026) for 1,900 units of naloxone and 800 safe drug deactivation systems annually for the county's community health program; the City of Tampa's IFB 26P00145 (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000 and sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, including Oregon, with awards effective July 1, 2026. The Texas HHS RFI HHS0017013 (posted April 3, 2026) represents exploratory market intelligence gathering rather than formal competitive solicitation, seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels.